Evidence map›Paper›PMID 22304911›Full record

ReviewCell2012

Hypoxia-inducible factors in physiology and medicine.

Gregg L Semenza

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05014087 (Digoxin In Treatment of Alcohol Associated Hepatitis), which is not on this map. Cited by 2,053 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,053citing papers in PubMed, 2 pooled it
77.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05014087 phase2terminatednot on this mapstarted 2021, after this paper: background citation

Digoxin In Treatment of Alcohol Associated Hepatitis (DIGIT-AlcHep)

TypeinterventionalSponsorYale UniversityRan2021 to 2025Enrolled23ConditionsAcute Alcoholic Hepatitis, Chemical and Drug Induced Liver Injury, Alcohol-Induced Disorders, Steatohepatitis Caused by Ingestible AlcoholArmsIntravenous digoxin
3 · Its place in the literature

Who cites it

2,053 citing papers in PubMed, 2 syntheses or guidelines pooled it, 3,310 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Cell plasticity in cancer and therapy resistance.Experimental & molecular medicine · 2026
    Review
  9. Review
  10. Review
  11. Multi-omics integration and machine learning identify an ACKR1Clinical and translational medicine · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Targeting FGF23 to Ameliorate Anemia in Chronic Kidney Disease.International journal of molecular sciences · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Article

1,993 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gregg L SemenzaVascular Program, Institute for Cell Engineering, Departments of Pediatrics, Medicine, Oncology, Radiation Oncology, and Biological Chemistry, McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. gsemenza@jhmi.edu
Johns Hopkins University · US

Funding

Stat3 in Post-Ischemic Myocardial InflammationP01HL065608 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BECKER, LEWIS C · 2000 to 2011
$22.0M
TRANS NETWORK PROJECTSU54CA143868 · NCI · JOHNS HOPKINS UNIVERSITY · PI WIRTZ, DENIS · 2009 to 2013
$13.7M
NCI NIH HHS U54 CA143868NCI NIH HHS U54-CA143868NHLBI NIH HHS HHSN268201000032CNHLBI NIH HHS P01 HL065608NHLBI NIH HHS P01-HL65608PHS HHS HHS-N268201000032C
6 · The paper itself

Abstract

Oxygen homeostasis represents an organizing principle for understanding metazoan evolution, development, physiology, and pathobiology. The hypoxia-inducible factors (HIFs) are transcriptional activators that function as master regulators of oxygen homeostasis in all metazoan species. Rapid progress is being made in elucidating homeostatic roles of HIFs in many physiological systems, determining pathological consequences of HIF dysregulation in chronic diseases, and investigating potential targeting of HIFs for therapeutic purposes.

Indexed as

Biological EvolutionAnimalsBasic Helix-Loop-Helix ProteinsChronic DiseaseEmbryonic DevelopmentHumansHypoxiaOxygenBasic Helix-Loop-Helix ProteinsOxygen

Identifiers

PMID22304911
PMCPMC3437543
OpenAlexW2087377825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.